Basal serum tryptase level correlates with severity of hymenoptera sting and age

Journal of Investigational Allergology and Clinical Immunology

Volumn 17, Issue 2, 2007, Pages 65-69

  Kucharewicz, Iwona ^a   Bodzenta Lukaszyk, A ^a   Szymanski, W ^a   Mroczko, B ^a   Szmitkowski, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hymenoptera venom allergy; Tryptase

Indexed keywords

BEE VENOM; HYMENOPTERA VENOM; TRYPTASE; WASP VENOM;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYMENOPTERA; INSECT ALLERGY; INSECT STING; MAJOR CLINICAL STUDY; MALE;

ADULT; AGE FACTORS; ANIMALS; BEES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TRYPTASES; WASPS;

EID: 34247219581     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, Metcalfe DD. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest. 1995;96:2702-10.
2. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest. 1989;83:1551-5.
3. Wenzel SE, Fowler AA, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis. 1988;137:1002-8.
4. Rasp G, Hochstrasser K. Tryptase in nasal fluid is a useful marker of allergic rhinitis. Allergy. 1993;48:72-4.
5. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5:359-64.
6. Golden DB. Patterns of anaphylaxis: acute and late phase features of allergic reactions. Novartis Found Symp. 2004;257:101-10.
7. Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet. 2001;357:361-2.
8. Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33:1216-20.
9. Mueller HL. Diagnosis and treatment of insect sensivity. J Astma Res. 1966;3:331-3.
10. Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60:1339-49.
11. Thurnheer U, Muller U, Stoller R, Lanner A, Hoigne R. Venom immunotherapy in Hymenoptera sting allergy. Allergy. 1983;38:465-75.
12. Pereira Santos MC, Pedro E, Spinola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy. Allerg Immunol. 2005;37:273-8.
13. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy. 2004;34:332-9.
14. Sturm GJ, Bohm E, Trummer M, Weiglhofer I., Heinemann A, Aberer W. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy. 2004;59:1110-17.
15. Binder M, Fierlbeck G, King T, Valent P, Buhring HJ. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol. 2002;29:160-8.
16. Lockey RF, Turkeltaub PC, Baird-Warren IA, Olive CA, Olive ES, Peppe BC, Bukantz SC. The Hymenoptera venom study I, 1979-1982: demographics and history-sting data. J Allergy Clin Immunol. 1988;82:370-81.
17. Lantner R, Reisman RE. Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol. 1989;84:900-6.
18. Przybilla B, Ring J, Grieshammer B. Association of features of atopy and diagnostic parameters in hymenoptera venom allergy Allergy. 1991;46:570-6.
19. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114:371-6.
20. Bonifazi, F, Jutel M, Bilo BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60:1459-70.
21. Sturm G, Wiednig M, Strele A, Schuster C, Aberrer W. Baseline serum tryptase levels and the severity of sting reactions in Hymenoptera venom allergy. XXV Congress of EAACI, Vienna 2006, Abstract book page 48.
22. Haeberli G, Meier R, Helbling A, Muller U. Severity of Hymenoptera venom allergy in correlation to basal tryptase levels. XXV Congress of EAACI, Vienna 2006, Abstract book page 48.
23. Akdis CA, Blaser K, Akdis M. Mechanisms of allergen-specific immunotherapy. Chem Immunol Allergy. 2006;91:195-203.
24. Ispas L, Henriksen RA, Metzger WJ. The many faces of systemic mastocytosis. Ann Allergy Asthma Immunol. 2001;87:6-14.
25. Biedermann T, Rueff F, Sander CA, Przybilla B. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels. Br J Dermatol. 1999;141:1110-12.
26. Koide T, Nakajima T, Makifuchi T, Fukuhara N. Systemic mastocytosis and recurrent anaphylactic shock. Lancet. 2002;359:2084.